stockportfolio.pro
Intuitive Surgical, Inc. (ISRG)
Healthcare · Medical Instruments & Supplies · NasdaqGS
Intuitive Surgical, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.71B | $3.14B | $3.72B | $4.48B | $4.36B | $5.71B | $6.22B | $7.12B | $8.35B | $10.06B |
| Gross profit | $1.89B | $2.20B | $2.60B | $3.11B | $2.86B | $3.96B | $4.20B | $4.73B | $5.63B | $6.64B |
| Net income | $738.30M | $670.90M | $1.13B | $1.38B | $1.06B | $1.70B | $1.32B | $1.80B | $2.32B | $2.86B |
| Net margin | 27.3% | 21.4% | 30.3% | 30.8% | 24.3% | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
Source: Intuitive Surgical, Inc. SEC filings (10-K). 19 years of history available in the interactive view.
What growth is priced into ISRG stock?
At today's market cap of $151.09B, Intuitive Surgical, Inc. is priced for free-cash-flow growth of about 22.9% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $2.49B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 16.9%/yr over the last five fiscal years and revenue 18.2%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 19 years of Intuitive Surgical, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ISRG in your portfolio →
Intuitive Surgical, Inc. financial history by metric
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Intuitive Surgical, Inc. — frequently asked questions
What is Intuitive Surgical, Inc.'s revenue?
Intuitive Surgical, Inc. (ISRG) reported revenue of $10.06B for fiscal year 2025, up 20.5% from the prior year, according to its SEC filings.
Is Intuitive Surgical, Inc. profitable?
Yes. ISRG earned net income of $2.86B in fiscal 2025, a net margin of 28.4%.
What is ISRG's P/E ratio?
Intuitive Surgical, Inc. trades at a price-to-earnings ratio of about 51.7 based on the latest data in our nightly-refreshed cache.
How fast is Intuitive Surgical, Inc. growing?
ISRG's revenue grew at roughly 18.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Intuitive Surgical, Inc. have?
As of fiscal year 2025, ISRG carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Intuitive Surgical, Inc.'s gross margin?
ISRG's gross margin was 66.0% in fiscal 2025 — gross profit of $6.64B on revenue of $10.06B.
What is Intuitive Surgical, Inc.'s market cap?
Intuitive Surgical, Inc. (ISRG) has a market capitalization of about $151.09B, based on the latest data in our nightly-refreshed cache.
When does Intuitive Surgical, Inc.'s fiscal year end?
ISRG's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ISRG stock?
At today's market cap of $151.09B, Intuitive Surgical, Inc. is priced for free-cash-flow growth of about 22.9% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $2.49B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 16.9%/yr over the last five fiscal years and revenue 18.2%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Intuitive Surgical, Inc.'s official SEC filings (10-K and 10-Q), covering 19 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.